Sunday, March 3

Tag: hydroxychloroquine

After Providing Hydroxychloroquine to World, India is working on Vaccine for COVID-19
INDIA

After Providing Hydroxychloroquine to World, India is working on Vaccine for COVID-19

Six Indian companies are working on a vaccine for COVID-19, joining global efforts to find a quick preventive for the deadly infection spreading rapidly across the world, says a top Indian scientist. Nearly 70 vaccine candidates' are being tested and at least three have moved to the human clinical trial stage, but a vaccine for the novel coronavirus is unlikely to be ready for mass use before 2021. As COVID-19 infects more than 1.9 million in the world and claims 1,26,000 lives, Indian scientists are also part of the global fight against the disease. While Zydus Cadila is working on two vaccines, Serum Institute, Biological E, Bharat Biotech, Indian Immunologicals, and Mynvax are developing one vaccine each. But it is a complicated process with many stages of testing and many ...
Donald Trump backed Sanofi will donate 100 million hydroxychloroquine doses
BUSINESS

Donald Trump backed Sanofi will donate 100 million hydroxychloroquine doses

Paris, April 10, 2020 – French drug firm Sanofi has committed to donating 100 million doses of hydroxychloroquine to 50 countries around the world and has begun to progressively deliver the medicine to authorities that have requested it. In this global health emergency, Sanofi said in a press release that we are ready to assist as many countries as possible, starting with countries where its medicine is registered for currently approved indications as well as countries where there are no hydroxychloroquine suppliers or countries with underserved populations. Since the beginning of the COVID-19 crisis, Sanofi has received a growing number of requests from local governments around the world. The company is regularly evaluating its increasing supply capacity and re-assessing how best t...
Trump has small financial interest hydroxychloroquine firm: NYT
USA

Trump has small financial interest hydroxychloroquine firm: NYT

President Donald Trump, who has aggressively promoted the use of hydroxychloroquine to treat coronavirus patients in and has asked India to export the anti-malarial drug to the US, has a small personal financial interest in the French pharma giant Sanofi, one of the manufacturers of the drug, according to a media report. Hydroxychloroquine, an old and inexpensive drug used to treat malaria, is seen as a viable therapeutic solution by President Trump to coronavirus that has so far killed more than 10,000 Americans and infected over 3.6 lakh within weeks. On Monday, Trump warned India that the US may retaliate if it did not export hydroxychloroquine despite his personal request, saying he would be surprised if New Delhi did not relent as it has good relations with Washington. If hy...